Active Since: 2015
Contributing to SDGs…
Improving the prevention, treatment and care for noncommunicable diseases (NCDs) in lower-income countries.
Academia or research institute
Duke NUS Medical School (Duke-NUS)
Management Sciences for Health (MSH)
Tropical Health and Education (THET)
World Heart Federation
All the ministries of health in the countries where Novartis Access is implemented. We also work with national procurement agencies.
Kenyatta National Hospital
American Cancer Society
Uganda Protestant Bureau (UPB)
Uganda Heart Institute (UHI)
Kenya Red Cross
Kenya Conference of Catholic Bishops and Christian Health Association Kenya (faith-based organisations)
Christian Health Association of Kenya
Cameroun Baptist Convention (CBC)
Mission for Essential Drugs and Supplies (MEDS)
Professional and trade associations
American Society for Clinical Pathology
World Heart Federation
- To improve prevention, treatment and care for noncommunicable diseases (NCDs) in lower-income countries.
What are the health needs and challenges?
Approximately 31 million people die each year from chronic non-communicable diseases (NCDs) in low– and middle–income countries, representing 80% of deaths from NCDs globally.
Partnership activities and how they address needs and challenges
The Novartis Access program makes available a portfolio of 15 critical chronic disease medicines to treat type 2 diabetes, cardiovascular diseases, respiratory illnesses, and breast cancer. These medicines are offered as a basket to governments, non-governmental organizations (NGOs) and other public-sector healthcare providers for USD 1 per treatment, per month. The aim is to make this innovative approach commercially sustainable over time, enabling continuous support in those regions.
Beyond the portfolio, we work with partners on the ground to offer capacity-building activities to support healthcare systems in preventing, diagnosing and treating chronic diseases.
We partner with organizations in four areas: community awareness and linkages to care, healthcare system strengthening, distribution and supply chain integrity, and advocacy and policy. These collaborations support the healthcare system through measures such as reinforcing drug distribution channels and training healthcare workers to diagnose and treat chronic illnesses. Novartis is also collaborating with Boston University in the US to evaluate the impact of Novartis Access in Kenya and steer ongoing development of Novartis Access.
SDGs THE PARTNERSHIP CONTRIBUTES TO
SDG 3: Good Health and Wellbeing
- 3.4: NCDs (including mental health)
- 3.C: Health workforce
SDG 9: Industry Innovation and Infrastructure
SDG 10: Reduced Inequalities
SDG 17: Partnerships for the Goals
RESULTS & MILESTONES
Since launch in 2015, Novartis Access has delivered more than 3 million monthly treatments to five countries (Cameroon, Ethiopia, Kenya, Rwanda and Uganda), and has signed agreements for 2019 implementation in Colombia, El Salvador, Pakistan and Nigeria.
- El Salvador
- Cardiovascular Diseases
- Respiratory Diseases
- Type 2